MaxCyte MXCT Other income, net (Note 6)
Other income, net (Note 6) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about MaxCyte's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MaxCyte's other income, net (note 6)?
- MaxCyte (MXCT) reported other income, net (note 6) of $1.44M in Q1 2026.
- How has MaxCyte's other income, net (note 6) changed year-over-year?
- MaxCyte's other income, net (note 6) decreased by 29.4% year-over-year, from $2.03M to $1.44M.
- What is the long-term trend for MaxCyte's other income, net (note 6)?
- Over 4 years (2021 to 2025), MaxCyte's other income, net (note 6) has grown at a 65.2% compound annual growth rate (CAGR), from -$974.6K to $7.27M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.